Drug information for ATAZANAVIR SULFATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 300MG Tentative Approval   ATAZANAVIR SULFATE atazanavir EMCURE PHARMS 200196
2010-08-24 Letter
CAPSULE; ORAL 100MG Tentative Approval   ATAZANAVIR SULFATE atazanavir EMCURE PHARMA 78785
2008-02-07 Letter
CAPSULE; ORAL 150MG Tentative Approval   ATAZANAVIR SULFATE atazanavir EMCURE PHARMA   "
CAPSULE; ORAL 200MG Tentative Approval   ATAZANAVIR SULFATE atazanavir EMCURE PHARMA   "
CAPSULE; ORAL 150MG Tentative Approval   ATAZANAVIR SULFATE atazanavir MATRIX LABS LTD 91611
2010-09-20 Letter
CAPSULE; ORAL 100MG Tentative Approval   ATAZANAVIR SULFATE atazanavir TEVA PHARMS USA 91673
CAPSULE; ORAL 150MG Tentative Approval   ATAZANAVIR SULFATE atazanavir TEVA PHARMS USA   "
CAPSULE; ORAL 200MG Tentative Approval   ATAZANAVIR SULFATE atazanavir TEVA PHARMS USA   "
CAPSULE; ORAL 300MG Tentative Approval   ATAZANAVIR SULFATE atazanavir TEVA PHARMS USA   "

Drug Adverse Effects information for ATAZANAVIR SULFATE

Role code Indications Reaction # Reports
SS HEPATITIS C CHOLECYSTECTOMY 1
SS HEPATITIS C CHOLELITHIASIS 1
SS HEPATITIS C PANCREATITIS 1
SS HIV INFECTION CHOLECYSTECTOMY 1
SS HIV INFECTION CHOLELITHIASIS 1
SS HIV INFECTION DRUG INTERACTION 3
SS HIV INFECTION PANCREATITIS 1
SS HIV INFECTION PANCREATITIS ACUTE 3
SS HYPERPHOSPHATAEMIA DRUG INTERACTION 1
SS HYPERPHOSPHATAEMIA PANCREATITIS ACUTE 1
SS HYPERTENSION DRUG INTERACTION 2
SS HYPERTENSION PANCREATITIS ACUTE 2
SS PRODUCT USED FOR UNKNOWN INDICATION CHOLECYSTECTOMY 2
SS PRODUCT USED FOR UNKNOWN INDICATION CHOLELITHIASIS 2
SS PRODUCT USED FOR UNKNOWN INDICATION PANCREATITIS 2
SS RENAL FAILURE DRUG INTERACTION 1
SS RENAL FAILURE PANCREATITIS ACUTE 1
C ALCOHOLIC LIVER DISEASE DIARRHOEA 4
C ALCOHOLIC LIVER DISEASE RENAL FAILURE ACUTE 4
C ALCOHOLIC LIVER DISEASE RHABDOMYOLYSIS 4
C ASCITES DIARRHOEA 3
C ASCITES RENAL FAILURE ACUTE 3
C ASCITES RHABDOMYOLYSIS 3
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS CONJUNCTIVITIS 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS INFLAMMATION 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS RASH 1
C DEPRESSION CONJUNCTIVITIS 2
C DEPRESSION INFLAMMATION 2
C DEPRESSION RASH 2
C GASTRODUODENAL ULCER HEPATIC FAILURE 1
C GASTRODUODENAL ULCER HEPATITIS CHOLESTATIC 1
C GASTRODUODENAL ULCER JAUNDICE 1
C HIV INFECTION CONJUNCTIVITIS 3
C HIV INFECTION DIARRHOEA 7
C HIV INFECTION HEPATIC FAILURE 4
C HIV INFECTION HEPATITIS CHOLESTATIC 4
C HIV INFECTION INFLAMMATION 3
C HIV INFECTION JAUNDICE 4
C HIV INFECTION PANCYTOPENIA 3
C HIV INFECTION RASH 3
C HIV INFECTION RENAL FAILURE ACUTE 7
C HIV INFECTION RHABDOMYOLYSIS 7
C PNEUMOCYSTIS JIROVECI PNEUMONIA DIARRHOEA 1
C PNEUMOCYSTIS JIROVECI PNEUMONIA RENAL FAILURE ACUTE 1
C PNEUMOCYSTIS JIROVECI PNEUMONIA RHABDOMYOLYSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 2
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 2
C PRODUCT USED FOR UNKNOWN INDICATION RHABDOMYOLYSIS 2
C PROPHYLAXIS AGAINST HIV INFECTION PANCYTOPENIA 1
C SYPHILIS DIARRHOEA 1
C SYPHILIS RENAL FAILURE ACUTE 1
C SYPHILIS RHABDOMYOLYSIS 1
C TOXOPLASMOSIS PROPHYLAXIS DIARRHOEA 1
C TOXOPLASMOSIS PROPHYLAXIS RENAL FAILURE ACUTE 1
C TOXOPLASMOSIS PROPHYLAXIS RHABDOMYOLYSIS 1
I ABNORMAL BEHAVIOUR DRUG INTERACTION 1
I ABNORMAL BEHAVIOUR ELECTROCARDIOGRAM QT PROLONGED 1
I ABNORMAL BEHAVIOUR SEDATION 1
I HIV INFECTION DRUG INTERACTION 4
I HIV INFECTION ELECTROCARDIOGRAM QT PROLONGED 4
I HIV INFECTION SEDATION 4
I MENTAL DISORDER DRUG INTERACTION 1
I MENTAL DISORDER ELECTROCARDIOGRAM QT PROLONGED 1
I MENTAL DISORDER SEDATION 1
I SCHIZOAFFECTIVE DISORDER DRUG INTERACTION 4
I SCHIZOAFFECTIVE DISORDER ELECTROCARDIOGRAM QT PROLONGED 4
I SCHIZOAFFECTIVE DISORDER SEDATION 4
Ads by Google